2024 |
Opus Genetics Inc.
|
Independent Director |
- |
- |
2024 |
Novavax, Inc.
|
Independent Director |
- |
- |
2024 |
Ardelyx Inc
|
Independent Director |
- |
- |
2024 |
Sagimet Biosciences Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2023 |
Ardelyx Inc
|
Independent Director |
222.4 K |
94.8 % |
2023 |
Novavax, Inc.
|
Independent Director |
191.8 K |
-70.0 % |
2023 |
Sagimet Biosciences Inc - Ordinary Shares - Class A
|
- |
45 K |
12.5 % |
2023 |
Opus Genetics Inc.
|
Independent Director |
- |
- |
2022 |
Novavax, Inc.
|
Independent Director |
639.5 K |
- |
2022 |
Ardelyx Inc
|
Independent Director |
114.2 K |
-48.6 % |
2022 |
Opus Genetics Inc.
|
Director, Interim President and Chief Executive Of |
91.5 K |
-37.9 % |
2022 |
Sagimet Biosciences Inc - Ordinary Shares - Class A
|
Independent Director |
40 K |
- |
2021 |
Ardelyx Inc
|
Independent Director |
221.9 K |
18.4 % |
2021 |
Opus Genetics Inc.
|
Independent Director |
147.3 K |
-27.0 % |
2020 |
Opus Genetics Inc.
|
Independent Director |
201.9 K |
- |
2020 |
Ardelyx Inc
|
Independent Director |
187.4 K |
15.7 % |
2019 |
Ardelyx Inc
|
Independent Director |
162.0 K |
46.3 % |
2019 |
Opus Genetics Inc.
|
Director |
- |
- |
2018 |
Ardelyx Inc
|
Independent Director |
110.7 K |
-1.2 % |
2017 |
Ardelyx Inc
|
Independent Director |
112.1 K |
-26.9 % |
2016 |
Ardelyx Inc
|
Independent Director |
153.2 K |
-24.5 % |
2015 |
Ardelyx Inc
|
Independent Director |
203.0 K |
-49.5 % |
2014 |
Ardelyx Inc
|
Independent Director |
402.2 K |
- |
2013 |
Ardelyx Inc
|
Independent Director |
- |
- |